HEMOCORM LIMITED
Significant control: Alfama Inc (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Hemocorm Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
HEMOCORM LIMITED is an active private limited company (company number 04647305) incorporated on 24 January 2003, registered in London. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest micro accounts cover the period ending 31 December 2024, showing net assets of −£555, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the bottom quarter of 654 comparable companies in London (median £101, upper quartile £41k).
Ownership and control
- Alfama Inc
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 January 200323 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 7 February 2027in 107 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- SIC 99999
- Dormant Company
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | −£555 | — | — | £12k | — | — | 0 |
| 31 December 2023 | −£555 | — | — | £12k | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-555 at 31 December 2024
- Current assets below creditors within one yearCurrent ratio 0.95
- Incorporated five or more years agoIncorporated 24 January 2003
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 107 days
- Next accounts due23 days overdue
- Accounts period endNet liabilities £555 · micro accounts
- Accounts period endNet liabilities £555 · micro accounts
- Incorporated
Similar companies in London
- ANCON TECHNOLOGIES LIMITEDLondon · inc. Jan 2003
- TECHNO-PRO LTDinc. Jan 2003
- GARRAD HASSAN GROUP LIMITEDLondon · inc. Feb 2003
- ENERGY DEMOCRACY PROJECT LTDLondon · inc. Feb 2003
- MERLIN SCIENTIFIC CONSULTING LIMITEDLondon · inc. Feb 2003
- VISICOMP RESEARCH LIMITEDinc. Dec 2002
All companies incorporated on 24 January 2003 · in Jan 2003.
Reminders for HEMOCORM LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.